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sPeripherally  inserted  central  catheters  have  become  essen-
tial  devices  for  continuous  or  intermittent  administration
of  intravenous  therapy,  from  intermediate  to  long-term,
especially  in  the  intensive  care  of  newborns.1 Known  in
clinical  practice  as  PICCs,  the  acronym  for  peripherally
inserted  central  catheters,  they  are  used  for  infusion  of
ﬂuids,  drugs,  parenteral  nutrition  and  blood  products,  pro-
moting  improved  quality  of  care  as  they  are  associated  with
reduction  of  pain  and  stress  caused  by  the  need  for  multiple
peripheral  venipuncture  procedures,  as  well  as  with  a pre-
sumed  lower  risk  of  complications  associated  with  central
venous  catheters.1,2
Since  the  ﬁrst  clinical  reports  of  PICC  use  in  the  1970s,
technological  improvement  of  raw  materials,  insertion  tech-
niques  and  performance  in  the  infusion  volume  maintenance
of  small-diameter  catheters  allowed  advances  in  the  care
of  newborns,  particularly  in  the  administration  of  drugs  and
solutions  with  extreme  pH  and  osmolarity,  or  solutions  that
are  vesicant  or  irritant  to  tissues.2,3
In  spite  of  the  beneﬁts,  the  use  of  PICC  in  newborns  is
characterized  as  a  complex  procedure  and  requires  the  use
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enting  good  practices  and  prevention  of  complications
elated  to  catheter  insertion,  maintenance  and  removal.  It
s  noteworthy  that,  although  PICCs  are  inserted  into  periph-
ral  veins,  daily  care  in  the  prevention  of  complications
iffers  from  that  intended  to  newborns  with  a  peripheral
ntravenous  catheter,  as  the  dimensions  and  location  of  the
atheter  tip  resemble  those  of  central  venous  insertion.3,4
In  neonates,  the  main  complications  related  to  the  use  of
ICC  are  catheter-related  bloodstream  infections,  as  well  as
atheter  obstruction,  migration  and  displacement.1,3 Simi-
ar  to  what  occurs  with  children,  a  meta-analysis  of  studies
n  adult  patients  demonstrated  that,  compared  to  central
atheters,  PICCs  were  associated  with  higher  risk  for  malpo-
itioning,  thrombophlebitis  and  mechanical  malfunctions.4
When  studying  559  newborns  who  used  626  PICCs,  the
ain  causes  of  complications  identiﬁed  were  presumed
epsis,  obstruction,  edema  or  inﬁltration,  catheter  break-
ge,  accidental  removal,  phlebitis,  pleural  effusion  and
alpositioning.5 The  incidence  of  complications  in  new-
orns  varies  markedly  among  studies,  from  zero  to  34%,  with
bstruction  being  highlighted  as  one  of  the  major  mechani-
al  complications.5--8PICC  obstruction  may  arise  from  thrombotic  or  non-
hrombotic,  partial  or  total  occlusion  of  the  catheter  lumen,
hich  limits  or  prevents  the  administration  of  solutions  or
spiration  of  blood  through  the  device.2 It  impairs  patient
evier Editora Ltda. All rights reserved.
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afety  by  causing  therapy  delay  or  interruption.  The  use  of
arger  caliber  PICCs  may  be  associated  with  increased  risk
f  occlusion  and  venous  thrombosis  development,  whereas
he  use  of  smaller-caliber  ones  can  contribute  to  PICC
bstruction  or  other  mechanical  malfunctions.1 The  non-
hrombotic  causes  of  catheter  obstruction  are  varied  and
ould  result  from  the  presence  of  mineral,  lipid  and  drug
recipitates,  catheter  folds,  sutures  that  are  too  tight,  and
alpositioning  of  the  catheter  due  to  its  placement  against
he  vessel  wall  or  being  compressed  by  the  collarbone
r  ﬁrst  rib.9 Studies  indicate  that  most  PICC  obstructions
re  thrombotic  and  result  from  ﬁbrin  deposition  inside  or
round  the  catheter  tip,  with  possible  evolution  to  severe
econdary  complications,  such  as  infection  and  catheter-
elated  thrombosis.2,9
In  an  article  published  in  this  issue,  Balaminut  et  al.10
tudied  the  efﬁcacy  of  two  low  molecular-weight  heparin
oncentrations  in  the  clearance  of  76  PICCs  removed  from
ewborns  after  being  used  and  stored  for  up  to  six  months
or  inclusion  in  the  study.  The  assessed  PICCs  were  submit-
ed  to  a  technique  to  promote  the  occurrence  of  thrombotic
bstruction  and  then  randomized  into  two  groups  --  one
elected  to  receive  a  dose  of  25U/mL  of  heparin,  and  the
ther,  a  dose  of  50U/mL.  The  technique  used  for  catheter
learance  was  the  negative  pressure  method  with  a  three-
ay  cannula,  and  in  each  study  group  a  professional  was
esponsible  for  implementing  the  proposed  technique  in  all
atheters  from  that  group.  The  ﬁndings  indicated  a  higher
ate  of  PICC  clearance  in  the  group  of  catheters  in  which  the
igher  concentration  of  heparin  was  used.
The  use  of  heparin,  including  the  low-molecular  weight
ype,  has  been  described  in  the  prevention  of  PICC
hrombotic  obstruction.11--13 The  use  of  heparin  as  an  antico-
gulant  is  most  often  used  in  the  intermittent  maintenance
f  catheters  and  shows  controversial  results;  however,  as
ontinuous  infusion,  in  PICC  occlusion  prophylaxis  in  new-
orns,  a  study  published  in  the  Cochrane  database  concluded
hat  there  was  a  preventive  effect,  although  without  enough
ower  to  determine  secondary  adverse  events,  requiring
linical  follow-up  of  the  results.11--14 Therefore,  despite  con-
roversies,  the  antithrombotic  activity  of  heparin  may  be
onsidered  in  clinical  practice  for  obstruction  prevention;
owever,  thrombolytic  action  is  not  attributed  to  this  drug,
s  proposed  in  the  study  by  Balaminut  et  al.  Their  ﬁndings
ere  probably  inﬂuenced  by  the  negative  pressure  tech-
ique  and  the  differences  between  groups  suffering  the
nﬂuence  of  the  mode  of  implementation  of  the  catheter
echanical  clearance  technique,  presupposing  that  the
rofessional  from  the  higher  heparin  concentration  group
erformed  the  clearance  technique  more  effectively.
For  PICC  clearance,  mechanical  techniques  with  differ-
nt  variations  have  been  described  and  routinely  used  in
linic  practice,  demonstrating  some  success  rates,  although
hey  must  be  used  with  stringent  criteria  due  to  the  risk
f  thrombus  displacement  inside  the  catheter  and  into  the
eonate’s  bloodstream.14--16 To  date,  regarding  thrombolytic
gents,  more  adequately  called  ﬁbrinolytic  agents,  there  are
ix  known  drugs,  with  alteplase  being  one  of  the  most  often
tudied  for  catheter  obstruction  reversal,  despite  adverse
eactions  that  restrict  its  use.9,16,17
Studies  have  shown  that  PICC  obstruction  is  character-
zed  as  a  preventable  adverse  event,  through  the  institution
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f  judicious  care  and  interventions,  constantly  updated
ased  on  the  best  evidence  that  support  the  practice
hen  handling  the  catheter.1,3,8 In  addition,  care  structure
hat  promotes  interdisciplinary  interventions  for  individual
anagement  of  newborns  with  PICC,  based  on  the  monitor-
ng  of  results  obtained  in  each  clinical  setting  and  on  the
nstitution  of  continuous  improvement  measures,  are  still
he  best  procedures  to  promote  catheter  removal  due  to
he  end  of  the  treatment  and  prevent  complications  that
an  compromise  the  quality  of  intravenous  therapy.
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